Literature DB >> 2533499

Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.

R F Sewell1, P E Brenchley, N P Mallick.   

Abstract

Xyloside-initiated 35SO4(2-)-labelled glycosaminoglycans were isolated from the medium of cultured bovine glomeruli and covalently coupled to Sepharose 4B to construct a solid-phase substrate suitable for the detection of endoglycosidases. The substrate is rendered specific for heparitinase by prior digestion with chondroitin sulphate ABC lyase and is insensitive to proteinase, neuraminidase and hyaluronidase. Normal human mononuclear cells are shown to contain a heparitinase. This enzyme appears to be cell-associated and can be partially purified from human spleen by heparin affinity chromatography.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2533499      PMCID: PMC1133653          DOI: 10.1042/bj2640777

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Stimulation of synthesis of free chondroitin sulfate chains by beta-D-xylosides in cultured cells.

Authors:  L Galligani; J Hopwood; N B Schwartz; A Dorfman
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

2.  A heparin-degrading endoglycosidase from rat spleen.

Authors:  M Höök; I Pettersson; S Ogren
Journal:  Thromb Res       Date:  1977-06       Impact factor: 3.944

3.  The effect of beta-xylosides on heparan sulfate synthesis by SV40-transformed Swiss mouse 3T3 cells.

Authors:  L S Johnston; J M Keller
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

4.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

Review 5.  Proteoglycan core protein families.

Authors:  J R Hassell; J H Kimura; V C Hascall
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

6.  Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells.

Authors:  R H Kramer; K G Vogel; G L Nicolson
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

7.  Glycosaminoglycan synthesis by cultured human skin fibroblasts after transformation with simian virus 40.

Authors:  J J Hopwood; A Dorfman
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

8.  Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides.

Authors:  J T Gallagher; A Walker
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

9.  Heparan sulfate proteoglycans from mouse mammary epithelial cells. Cell surface proteoglycan as a receptor for interstitial collagens.

Authors:  J E Koda; A Rapraeger; M Bernfield
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

10.  Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.

Authors:  M Bar-Ner; M D Kramer; V Schirrmacher; R Ishai-Michaeli; Z Fuks; I Vlodavsky
Journal:  Int J Cancer       Date:  1985-04-15       Impact factor: 7.396

View more
  9 in total

Review 1.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  A rapid quantitative assay for the detection of mammalian heparanase activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 4.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

5.  Evidence that platelet and tumour heparanases are similar enzymes.

Authors:  C Freeman; A M Browne; C R Parish
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

6.  Human platelet heparanase: purification, characterization and catalytic activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

Review 7.  Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation.

Authors:  Catherine B Kirn-Safran; Sonia S D'Souza; Daniel D Carson
Journal:  Semin Cell Dev Biol       Date:  2007-07-31       Impact factor: 7.727

8.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

9.  Macrophage migration inhibitory factor antagonist (p425) ameliorates kidney histopathological and functional changes in diabetic rats.

Authors:  Jamal Khalilpour; Shiva Roshan-Milani; Farzaneh Hosseini Gharalari; Amin Abdollahzade Fard
Journal:  J Bras Nefrol       Date:  2019-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.